Lifevantage (LFVN) Cash & Equivalents (2010 - 2026)

Lifevantage (LFVN) has 17 years of Cash & Equivalents data on file, last reported at $12.5 million in Q1 2026.

• Quarterly Cash & Equivalents fell 44.44% year-over-year to $12.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.5 million (down 44.44% YoY) and the FY2025 annual result came in at $20.2 million, up 19.63% from the prior year.
• Cash & Equivalents grew to $12.5 million in Q1 2026, from $10.2 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $22.5 million in Q1 2025 to a low of $10.2 million in Q4 2025.
• A 5-year average of $17.6 million and a median of $17.6 million in 2022 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 29.3% in 2025, down 52.85% in 2025.
• Tracing LFVN's Cash & Equivalents over 5 years: stood at $17.4 million in 2022, then fell by 0.22% to $17.3 million in 2023, then climbed by 24.6% to $21.6 million in 2024, then sank by 52.85% to $10.2 million in 2025, then increased by 22.61% to $12.5 million in 2026.
• The last three Cash & Equivalents figures came in at $12.5 million (Q1 2026), $10.2 million (Q4 2025), and $13.1 million (Q3 2025), per Business Quant data.